A previous study enrolled 107 primary breast tumors of patients who had developed distant metastasis and classified all patients into two groups according to the site of relapse (bone vs. non-bone), finding that AGR2 was highly expressed in the samples with relapse to bone (26). This evidence concerns the gene AGR2 and breast neoplasm.